{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:43:53Z","timestamp":1791355433208,"version":"4.3.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T00:00:00Z","timestamp":1497052800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00406-017-0815-9","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T15:58:58Z","timestamp":1497110338000},"page":"519-524","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Plasma levels of soluble amyloid precursor protein \u03b2 in symptomatic Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"268","author":[{"given":"Panagiotis","family":"Alexopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena-Sophie","family":"Gleixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Werle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Thierjung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Giourou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone M.","family":"Kagerbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippos","family":"Gourzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"K\u00fcbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Grimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Yakushev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Perneczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,10]]},"reference":[{"issue":"6","key":"815_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C et al (2014) Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol 13(6):614\u2013629. doi:\n                        10.1016\/S1474-4422(14)70090-0","journal-title":"Lancet Neurol"},{"issue":"23","key":"815_CR2","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1001\/jama.2011.810","volume":"305","author":"GM McKhann","year":"2011","unstructured":"McKhann GM (2011) Changing concepts of Alzheimer disease. JAMA 305(23):2458\u20132459. doi:\n                        10.1001\/jama.2011.810","journal-title":"JAMA"},{"issue":"6","key":"815_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1159\/000441327","volume":"48","author":"P Alexopoulos","year":"2015","unstructured":"Alexopoulos P, Kurz A (2015) The new conceptualization of Alzheimer\u2019s disease under the microscope of influential definitions of disease. Psychopathology 48(6):359\u2013367. doi:\n                        10.1159\/000441327","journal-title":"Psychopathology"},{"issue":"7","key":"815_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00406-010-0105-2","volume":"260","author":"D Martins-de-Souza","year":"2010","unstructured":"Martins-de-Souza D (2010) Is the word \u2018biomarker\u2019 being properly used by proteomics research in neuroscience? Eur Arch Psychiatry Clin Neurosci 260(7):561\u2013562. doi:\n                        10.1007\/s00406-010-0105-2","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"815_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jalz.2016.09.009","volume":"13","author":"S-K Herukka","year":"2017","unstructured":"Herukka S-K, Simonsen AH, Andreasen N et al (2017) Recommendations for cerebrospinal fluid Alzheimer\u2019s disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer\u2019s Dement 13(3):285\u2013295. doi:\n                        10.1016\/j.jalz.2016.09.009","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"815_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jalz.2016.09.008","volume":"13","author":"AH Simonsen","year":"2017","unstructured":"Simonsen AH, Herukka S-K, Andreasen N et al (2017) Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer\u2019s Dement 13(3):274\u2013284. doi:\n                        10.1016\/j.jalz.2016.09.008","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"815_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jalz.2005.11.001","volume":"2","author":"BL Plassman","year":"2006","unstructured":"Plassman BL, Khachaturian AS, Townsend JJ et al (2006) Comparison of clinical and neuropathologic diagnoses of Alzheimer\u2019s disease in 3 epidemiologic samples. Alzheimer\u2019s Dement 2(1):2\u201311. doi:\n                        10.1016\/j.jalz.2005.11.001","journal-title":"Alzheimer\u2019s Dement"},{"key":"815_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.11.007","author":"MW Weiner","year":"2017","unstructured":"Weiner MW, Veitch DP, Aisen PS et al (2017) Recent publications from the Alzheimer\u2019s disease neuroimaging initiative: reviewing progress toward improved AD clinical trials. Alzheimer\u2019s Dement. doi:\n                        10.1016\/j.jalz.2016.11.007","journal-title":"Alzheimer\u2019s Dement"},{"issue":"9","key":"815_CR9","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1093\/brain\/awv181","volume":"138","author":"T Skillb\u00e4ck","year":"2015","unstructured":"Skillb\u00e4ck T, Farahmand BY, Ros\u00e9n C et al (2015) Cerebrospinal fluid tau and amyloid-\u03b21-42 in patients with dementia. Brain 138(9):2716\u20132731. doi:\n                        10.1093\/brain\/awv181","journal-title":"Brain"},{"issue":"6","key":"815_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jalz.2014.03.006","volume":"10","author":"P Alexopoulos","year":"2014","unstructured":"Alexopoulos P, Kriett L, Haller B et al (2014) Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 10(6):684\u2013689. doi:\n                        10.1016\/j.jalz.2014.03.006","journal-title":"Alzheimer\u2019s Dement"},{"key":"815_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-015-0628-7","author":"P Alexopoulos","year":"2015","unstructured":"Alexopoulos P, Roesler J, Thierjung N et al (2015) Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer\u2019s disease. Eur Arch Psychiatry Clin Neurosci. doi:\n                        10.1007\/s00406-015-0628-7","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"815_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 7(3):263\u2013269. doi:\n                        10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"815_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 7(3):270\u2013279. doi:\n                        10.1016\/j.jalz.2011.03.008","journal-title":"Alzheimer\u2019s Dement"},{"issue":"2","key":"815_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ana.23931","volume":"74","author":"RC Petersen","year":"2013","unstructured":"Petersen RC, Aisen P, Boeve BF et al (2013) Mild cognitive impairment due to Alzheimer disease in the community. Ann Neurol 74(2):199\u2013208. doi:\n                        10.1002\/ana.23931","journal-title":"Ann Neurol"},{"issue":"1","key":"815_CR15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molmed.2013.10.001","volume":"20","author":"R Perneczky","year":"2014","unstructured":"Perneczky R, Alexopoulos P, Kurz A (2014) Soluble amyloid precursor proteins and secretases as Alzheimer\u2019s disease biomarkers. Trends Mol Med 20(1):8\u201315","journal-title":"Trends Mol Med"},{"key":"815_CR16","doi-asserted-by":"publisher","first-page":"CD010632","DOI":"10.1002\/14651858.CD010632.pub2","volume":"1","author":"N Smailagic","year":"2015","unstructured":"Smailagic N, Vacante M, Hyde C (2015) 18F-FDG PET for the early diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 1:CD010632. doi:\n                        10.1002\/14651858.CD010632.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"815_CR17","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1038\/tp.2013.11","volume":"3","author":"R Perneczky","year":"2013","unstructured":"Perneczky R, Guo LH, Kagerbauer SM et al (2013) Soluble amyloid precursor protein beta as blood-based biomarker of Alzheimer\u2019s disease. Transl Psychiatry 3:e227. doi:\n                        10.1038\/tp.2013.11","journal-title":"Transl Psychiatry"},{"issue":"6","key":"815_CR18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/jnr.22618","volume":"89","author":"G Wu","year":"2011","unstructured":"Wu G, Sankaranarayanan S, Hsieh SH-K et al (2011) Decrease in brain soluble amyloid precursor protein beta (sAPPbeta) in Alzheimer\u2019s disease cortex. J Neurosci Res 89(6):822\u2013832. doi:\n                        10.1002\/jnr.22618","journal-title":"J Neurosci Res"},{"issue":"1","key":"815_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000093101","volume":"22","author":"P Alexopoulos","year":"2006","unstructured":"Alexopoulos P, Grimmer T, Perneczky R et al (2006) Progression to dementia in clinical subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord 22(1):27\u201334. doi:\n                        10.1159\/000093101","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"815_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pscychresns.2009.08.001","volume":"181","author":"R Perneczky","year":"2010","unstructured":"Perneczky R, Drzezga A, Boecker H et al (2010) Metabolic alterations associated with impaired clock drawing in Lewy body dementia. Psychiatry Res 181(2):85\u201389. doi:\n                        10.1016\/j.pscychresns.2009.08.001","journal-title":"Psychiatry Res"},{"issue":"2","key":"815_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3233\/JAD-122329","volume":"36","author":"P Alexopoulos","year":"2013","unstructured":"Alexopoulos P, Guo L-H, Jiang M et al (2013) Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer\u2019s disease cerebral metabolic signature. J Alzheimers Dis 36(2):401\u2013408. doi:\n                        10.3233\/JAD-122329","journal-title":"J Alzheimers Dis"},{"issue":"15","key":"815_CR22","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","volume":"73","author":"WJ Jagust","year":"2009","unstructured":"Jagust WJ, Landau SM, Shaw LM et al (2009) Relationships between biomarkers in aging and dementia. Neurology 73(15):1193\u20131199. doi:\n                        10.1212\/WNL.0b013e3181bc010c","journal-title":"Neurology"},{"issue":"8","key":"815_CR23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","volume":"52","author":"F Hulstaert","year":"1999","unstructured":"Hulstaert F, Blennow K, Ivanoiu A et al (1999) Improved discrimination of AD patients using beta-amyloid (1\u201342) and tau levels in CSF. Neurology 52(8):1555\u20131562","journal-title":"Neurology"},{"issue":"8750","key":"815_CR24","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0140-6736(91)92823-K","volume":"337","author":"PR Wenham","year":"1991","unstructured":"Wenham PR, Price WH, Blandell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet (London, England) 337(8750):1158\u20131159","journal-title":"Lancet (London, England)"},{"issue":"7","key":"815_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U et al (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease. A systematic review and meta-analysis. Lancet Neurol 15(7):673\u2013684. doi:\n                        10.1016\/S1474-4422(16)00070-3","journal-title":"Lancet Neurol"},{"key":"815_CR26","doi-asserted-by":"publisher","unstructured":"Zhang S, Smailagic N, Hyde C et al. (2014) 11C-PIB-PET for the early diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev (7):CD010386. doi:\n                        10.1002\/14651858.CD010386.pub2","DOI":"10.1002\/14651858.CD010386.pub2"},{"issue":"12","key":"815_CR27","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.clinbiochem.2008.04.022","volume":"41","author":"G Wu","year":"2008","unstructured":"Wu G, Sankaranarayanan S, Tugusheva K et al (2008) Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer\u2019s subjects. Clin Biochem 41(12):986\u2013996. doi:\n                        10.1016\/j.clinbiochem.2008.04.022","journal-title":"Clin Biochem"},{"issue":"48","key":"815_CR28","doi-asserted-by":"publisher","first-page":"40817","DOI":"10.1074\/jbc.M112.398578","volume":"287","author":"S Kitazume","year":"2012","unstructured":"Kitazume S, Yoshihisa A, Yamaki T et al (2012) Soluble amyloid precursor protein 770 is released from inflamed endothelial cells and activated platelets: a novel biomarker for acute coronary syndrome. J Biol Chem 287(48):40817\u201340825. doi:\n                        10.1074\/jbc.M112.398578","journal-title":"J Biol Chem"},{"issue":"4","key":"815_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/15672026113109990022","volume":"10","author":"J Marksteiner","year":"2013","unstructured":"Marksteiner J, Humpel C (2013) Platelet-derived secreted amyloid-precursor protein-beta as a marker for diagnosing Alzheimer\u2019s disease. Curr Neurovasc Res 10(4):297\u2013303","journal-title":"Curr Neurovasc Res"},{"issue":"6","key":"815_CR30","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.neurobiolaging.2012.12.004","volume":"34","author":"E Delvaux","year":"2013","unstructured":"Delvaux E, Bentley K, Stubbs V et al (2013) Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes. Neurobiol Aging 34(6):1680\u20131686. doi:\n                        10.1016\/j.neurobiolaging.2012.12.004","journal-title":"Neurobiol Aging"},{"issue":"4","key":"815_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-015-1477-1","volume":"130","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Bu X-L, Liu Y-H et al (2015) Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol 130(4):487\u2013499. doi:\n                        10.1007\/s00401-015-1477-1","journal-title":"Acta Neuropathol"},{"issue":"1","key":"815_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","volume":"5","author":"AE Roher","year":"2009","unstructured":"Roher AE, Esh CL, Kokjohn TA et al (2009) Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 5(1):18\u201329. doi:\n                        10.1016\/j.jalz.2008.10.004","journal-title":"Alzheimer\u2019s Dement"},{"issue":"2","key":"815_CR33","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/039463201102400229","volume":"24","author":"A Vignini","year":"2011","unstructured":"Vignini A, Sartini D, Morganti S et al (2011) Platelet amyloid precursor protein isoform expression in Alzheimer\u2019s disease: evidence for peripheral marker. Int J Immunopathol Pharmacol 24(2):529\u2013534","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"815_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/ajmg.b.10067","volume":"118B","author":"S Jiang","year":"2003","unstructured":"Jiang S, Zhang M, Ren D et al (2003) Enhanced production of amyloid precursor protein mRNA by peripheral mononuclear blood cell in Alzheimer\u2019s disease. American journal of medical genetics. Part B Psychiatr Genet 118B(1):99\u2013102. doi:\n                        10.1002\/ajmg.b.10067","journal-title":"Part B Psychiatr Genet"},{"issue":"1","key":"815_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1471-4159.2011.07584.x","volume":"120","author":"S Chasseigneaux","year":"2012","unstructured":"Chasseigneaux S, Allinquant B (2012) Functions of Abeta, sAPPalpha and sAPPbeta. Similarities and differences. J Neurochem 120(1):99\u2013108. doi:\n                        10.1111\/j.1471-4159.2011.07584.x","journal-title":"J Neurochem"},{"issue":"48","key":"815_CR36","doi-asserted-by":"publisher","first-page":"40817","DOI":"10.1074\/jbc.M112.398578","volume":"287","author":"S Kitazume","year":"2012","unstructured":"Kitazume S, Yoshihisa A, Yamaki T et al (2012) Soluble amyloid precursor protein 770 is released from inflamed endothelial cells and activated platelets: a novel biomarker for acute coronary syndrome. J Bio Chem 287(48):40817\u201340825. doi:\n                        10.1074\/jbc.M112.398578","journal-title":"J Bio Chem"},{"key":"815_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-015-0628-7","author":"P Alexopoulos","year":"2015","unstructured":"Alexopoulos P, Roesler J, Thierjung N et al (2015) Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer\u2019s disease. Eur Arch Psychiatry Clin Neurosci. doi:\n                        10.1007\/s00406-015-0628-7","journal-title":"Eur Arch Psychiatry Clin Neurosci"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-017-0815-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-017-0815-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-017-0815-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T15:24:01Z","timestamp":1530631441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-017-0815-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["815"],"URL":"https:\/\/doi.org\/10.1007\/s00406-017-0815-9","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,10]]}}}